Comparison of Family History and SNPs for Predicting Risk of Complex Disease

English version České info

The clinical utility of family history and genetic tests is generally well understood for simple Mendelian disorders and rare subforms of complex diseases that are directly attributable to highly penetrant genetic variants. However, little is presently known regarding the performance of these methods in situations where disease susceptibility depends on the cumulative contribution of multiple genetic factors of moderate or low penetrance. Using quantitative genetic theory, we develop a model for studying the predictive ability of family history and single nucleotide polymorphism (SNP)–based methods for assessing risk of polygenic disorders. We show that family history is most useful for highly common, heritable conditions (e.g., coronary artery disease), where it explains roughly 20%–30% of disease heritability, on par with the most successful SNP models based on associations discovered to date. In contrast, we find that for diseases of moderate or low frequency (e.g., Crohn disease) family history accounts for less than 4% of disease heritability, substantially lagging behind SNPs in almost all cases. These results indicate that, for a broad range of diseases, already identified SNP associations may be better predictors of risk than their family history–based counterparts, despite the large fraction of missing heritability that remains to be explained. Our model illustrates the difficulty of using either family history or SNPs for standalone disease prediction. On the other hand, we show that, unlike family history, SNP–based tests can reveal extreme likelihood ratios for a relatively large percentage of individuals, thus providing potentially valuable adjunctive evidence in a differential diagnosis.

Vyšlo v časopise: Comparison of Family History and SNPs for Predicting Risk of Complex Disease. PLoS Genet 8(10): e32767. doi:10.1371/journal.pgen.1002973
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002973

Souhrn

Zdroje

1. HindorffLA, SethupathyP, JunkinsHA, RamosEM, MehtaJP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106: 9362–9367.

2. ManolioTA, CollinsFS, CoxNJ, GoldsteinDB, HindorffLA, et al. (2009) Finding the missing heritability of complex diseases. Nature 461: 747–753.

3. MaherB (2008) Personal genomes: The case of the missing heritability. Nature 456: 18–21.

4. EichlerEE, FlintJ, GibsonG, KongA, LealSM, et al. (2010) Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 11: 446–450.

5. SoHC, GuiAH, ChernySS, ShamPC (2011) Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet Epidemiol 35: 310–317.

6. GuttmacherAE, CollinsFS, CarmonaRH (2004) The family history–more important than ever. N Engl J Med 351: 2333–2336.

7. YoonPW, ScheunerMT, Peterson-OehlkeKL, GwinnM, FaucettA, et al. (2002) Can family history be used as a tool for public health and preventive medicine? Genet Med 4: 304–310.

8. YoonPW, ScheunerMT, JorgensenC, KhouryMJ (2009) Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis 6: A33.

9. O'NeillSM, RubinsteinWS,WangC, YoonPW, AchesonLS, et al. (2009) Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med 36: 506–514.

10. HealdB, EdelmanE, EngC (2012) Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers. Eur J Hum Genet In press.

11. SoHC, KwanJS, ChernySS, ShamPC (2011) Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening. Am J Hum Genet 88: 548–565.

12. RuderferDM, KornJ, PurcellSM (2010) Family-based genetic risk prediction of multifactorial disease. Genome Med 2: 2.

13. KhouryMJ, FeeroWG, ValdezR (2010) Family history and personal genomics as tools for improving health in an era of evidence-based medicine. Am J Prev Med 39: 184–188.

14. FalconerDS (1965) The inheritance of liability to certain diseases, estimated from the incidence among relatives. Annals of Human Genetics 29: 51–76.

15. GailMH, BrintonLA, ByarDP, CorleDK, GreenSB, et al. (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81: 1879–1886.

16. WrayNR, YangJ, GoddardME, VisscherPM (2010) The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genet 6: e1000864.

17. SoHC, ShamPC (2010) A unifying framework for evaluating the predictive power of genetic variants based on the level of heritability explained. PLoS Genet 6: e1001230.

18. KohaneIS, MasysDR, AltmanRB (2006) The incidentalome: a threat to genomic medicine. JAMA 296: 212–215.

19. ChenS, ParmigianiG (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25: 1329–1333.

20. ClaytonDG (2009) Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet 5: e1000540.

21. HallWD, MathewsR, MorleyKI (2010) Being more realistic about the public health impact of genomic medicine. PLoS Med 7: e1000347.

22. RobertsNJ, VogelsteinJT, ParmigianiG, KinzlerKW, VogelsteinB, et al. (2012) The predictive capacity of personal genome sequencing. Sci Transl Med 4: 133ra58.

23. MortonNE, MacLeanCJ (1974) Analysis of family resemblance. 3. Complex segregation of quantitative traits. Am J Hum Genet 26: 489–503.

24. MaloneKE, DalingJR, DoodyDR, HsuL, BernsteinL, et al. (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66: 8297–8308.

25. RischHA, McLaughlinJR, ColeDE, RosenB, BradleyL, et al. (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68: 700–710.

26. NussbaumRL, EllisCE (2003) Alzheimer's disease and Parkinson's disease. N Engl J Med 348: 1356–1364.

27. HillWG, GoddardME, VisscherPM (2008) Data and theory point to mainly additive genetic variance for complex traits. PLoS Genet 4: e1000008.

28. CzeneK, LichtensteinP, HemminkiK (2002) Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 99: 260–266.

29. Lynch M, Walsh B (1998) Genetics and Analysis of Quantitative Traits. Sinauer.URL http://books.google.com/books?id=UhCCQgAACAAJ.

30. Falconer D (1989) Introduction to quantitative genetics. Longman, Scientific & Technical.URL http://books.google.com/books?id=on_wAAAAMAAJ.

31. VisscherPM, HillWG, WrayNR (2008) Heritability in the genomics era–concepts and misconceptions. Nat Rev Genet 9: 255–266.

32. ZukO, HechterE, SunyaevSR, LanderES (2012) The mystery of missing heritability: Genetic interactions create phantom heritability. Proc Natl Acad Sci U S A In press.

33. ScheunerMT, WangSJ, RaffelLJ, LarabellSK, RotterJI (1997) Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet 71: 315–324.

34. YoonPW, ScheunerMT, KhouryMJ (2003) Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med 24: 128–135.

35. RuffinMT, NeaseDE, SenA, PaceWD, WangC, et al. (2011) Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial. Ann Fam Med 9: 3–11.

36. RansohoffDF, KhouryMJ (2010) Personal genomics: information can be harmful. Eur J Clin Invest 40: 64–68.

37. Qureshi N, Wilson B, Santaguida P, Carroll J, Allanson J, et al.. (2007). Collection and use of cancer family history in primary care. Evidence Report/Technology Assessment No. 159 (prepared by the McMaster University Evidence-based Practice Center, under Contract No. 290-02-0020). AHRQ Publication No. 08-E001. Rockville, MD: Agency for Healthcare Research and Quality. October 2007.

38. RubinsteinWS, AchesonLS, O'NeillSM, RuffinMT, WangC, et al. (2011) Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial. Genet Med 13: 956–965.

39. JanssensAC, MoonesingheR, YangQ, SteyerbergEW, van DuijnCM, et al. (2007) The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet Med 9: 528–535.

40. BodmerW, BonillaC (2008) Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40: 695–701.

41. GenzA (1992) Numerical computation of multivariate normal probabilities. J Comp Graph Stat 1: 141–149.

42. DudbridgeF, GusnantoA (2008) Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 32: 227–234.

43. 1000 Genomes Project Consortium (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061–1073.

44. RischNJ (2000) Searching for genetic determinants in the new millennium. Nature 405: 847–856.

45. LohmuellerKE, PearceCL, PikeM, LanderES, HirschhornJN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33: 177–182.

46. GhoshA, ZouF, WrightFA (2008) Estimating odds ratios in genome scans: an approximate conditional likelihood approach. Am J Hum Genet 82: 1064–1074.

47. DuboisPC, TrynkaG, FrankeL, HuntKA, RomanosJ, et al. (2010) Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 42: 295–302.

48. FrankeA, McGovernDP, BarrettJC, WangK, Radford-SmithGL, et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 42: 1118–1125.

49. BarrettJH, IlesMM, HarlandM, TaylorJC, AitkenJF, et al. (2011) Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 43: 1108–1113.

50. SawcerS, HellenthalG, PirinenM, SpencerCC, PatsopoulosNA, et al. (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214–219.

51. DoCB, TungJY, DorfmanE, KieferAK, DrabantEM, et al. (2011) Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet 7: e1002141.

52. LanktreeMB, DichgansM, HegeleRA (2010) Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke 41: 825–832.

53. AndersonCA, BoucherG, LeesCW, FrankeA, D'AmatoM, et al. (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43: 246–252.